Loading…
Skye Bioscience, Inc. is projected to rise to $0.7465 by 2027, a +7% move from its current price of $0.69. SKYE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.6688 | $0.6897 | $0.7113 | -0.04% |
| Jul 14 | $0.66 | $0.6894 | $0.7201 | -0.08% |
| Jul 15 | $0.6533 | $0.6891 | $0.7269 | -0.13% |
| Jul 16 | $0.6477 | $0.6888 | $0.7326 | -0.17% |
| Jul 17 | $0.6427 | $0.6885 | $0.7377 | -0.21% |
| Jul 18 | $0.6382 | $0.6883 | $0.7422 | -0.25% |
| Jul 19 | $0.6341 | $0.688 | $0.7464 | -0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6341 | $0.688 | $0.7464 | -0.30% |
| Week 2 | $0.6112 | $0.6859 | $0.7698 | -0.59% |
| Week 3 | $0.5938 | $0.6839 | $0.7876 | -0.88% |
| Week 4 | $0.5793 | $0.6819 | $0.8027 | -1.18% |
| Week 5 | $0.5666 | $0.6799 | $0.8159 | -1.47% |
| Week 6 | $0.5551 | $0.6779 | $0.8277 | -1.76% |
| Week 7 | $0.5447 | $0.6759 | $0.8386 | -2.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Skye Bioscience, Inc. is a clinical-stage biotechnology company focused on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation.
The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021.
Skye Bioscience, Inc. is headquartered in San Diego, California.
Skye Bioscience trades under the symbol SKYE and has a current price of $0.6705. Its market capitalization is $23.56M, and it is ranked 4586 by market cap and liquidity considerations.
The latest price action sits in a low-capitalization niche with a modest trading footprint. The 30-day forecast shows an average price near the current level, with upside potential over time according to the projected path.
Forecasts depict a near-term flat-to-modestly rising price path through 2026–2028, followed by stronger upside into 2029–2050. The 2026 average price is $0.6705, with a max of $0.7931 and a min of $0.577. The long-run picture shows rising averages and higher max values, culminating in 2050 with an average of $3.16 and a max of $6.62.
Overall, the outlook shifts from neutral in the early years to bullish in the later years, with increasing upside reflected in the 2030, 2040, and 2050 forecast figures.
A major floor 19.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.8% away) — a key level to hold.
The nearest ceiling, 23.2% above — a clean break opens room to run.
A major ceiling 53.6% above — clearing it would confirm fresh momentum.
Key SKYE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SKYE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.70 | Sell | $0.6965 | Sell |
| MA 10 | $0.692 | Sell | $0.6985 | Sell |
| MA 20 | $0.7085 | Sell | $0.7114 | Sell |
| MA 50 | $0.7694 | Sell | $0.7469 | Sell |
| MA 100 | $0.7547 | Sell | $0.8471 | Sell |
| MA 200 | $1.10 | Sell | $1.25 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.31 | Neutral |
| Stoch RSI (14) | 65.98 | Neutral |
| CCI (20) | -60.16 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -1.43 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | -0.48 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 46.07 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 0.70 | Sell |
| ADX (14) | 12.14 | Neutral |
| ATR (14) | 0.02 | Info |
The near-term technical picture is Bearish. The RSI(14) is 40, and the stock trades below the 50-day moving average of $0.8011 while the 200-day moving average sits at $1.23.
Support is noted at $0.671 and resistance at $0.85. The 30-day price range runs from a low of $0.5248 to a high of $0.8566, framing a tight but potentially volatile near-term band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.577 | $0.7009 | $0.8181 | 0% | Neutral | |
| $0.5871 | $0.7465 | $1.01 | +7% | Neutral | |
| $0.5988 | $0.786 | $1.11 | +12% | Neutral | |
| $0.6837 | $0.9216 | $1.34 | +31% | Bullish | |
| $0.7848 | $1.08 | $1.62 | +55% | Bullish | |
| $0.7403 | $1.04 | $1.59 | +49% | Bullish | |
| $0.7485 | $1.08 | $1.68 | +54% | Bullish | |
| $0.7496 | $1.10 | $1.75 | +57% | Bullish | |
| $0.7099 | $1.06 | $1.71 | +51% | Bullish | |
| $0.8991 | $1.37 | $2.24 | +95% | Bullish | |
| $0.9938 | $1.63 | $2.87 | +133% | Bullish | |
| $1.87 | $3.53 | $6.83 | +403% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.577 | $0.7009 | $0.8095 | +1.58% |
| August 2026 | $0.5526 | $0.6546 | $0.798 | -6.61% |
| September 2026 | $0.556 | $0.6639 | $0.8195 | +1.42% |
| October 2026 | $0.5433 | $0.6531 | $0.8146 | -1.63% |
| November 2026 | $0.5203 | $0.6291 | $0.7916 | -3.67% |
| December 2026 | $0.5306 | $0.6451 | $0.8181 | +2.53% |
Click any year to see its month-by-month SKYE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SKYE could reach as high as $0.8181, with a base case around $0.7009 and support toward $0.577 — roughly 0% from $0.69. A consolidation phase looks the most probable path here.
Expect SKYE to range from $0.5871 to $1.01 through 2027. The $0.7465 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. Price action looks broadly range-bound.
The SKYE price prediction for 2028 points to an average of $0.786 (low $0.5988, high $1.11) — a potential gain of +12% on today's $0.69. A consolidation phase looks the most probable path here.
In 2029, SKYE is projected to trade between $0.6837 and $1.34, averaging $0.9216 — a potential gain of +31% from today's $0.69. That is up +17% on the projected 2028 average. Momentum favours further upside here.
Skye Bioscience, Inc.'s 2030 outlook centres on $1.08, within a $0.7848 to $1.62 range. That is up +18% on the projected 2029 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, SKYE could reach as high as $1.59, with a base case around $1.04 and support toward $0.7403 — roughly +49% from $0.69. Momentum favours further upside here.
Expect SKYE to range from $0.7485 to $1.68 through 2032. The $1.08 average target implies a +54% move from current prices. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SKYE price prediction for 2033 points to an average of $1.10 (low $0.7496, high $1.75) — a potential gain of +57% on today's $0.69. Momentum favours further upside here.
In 2034, SKYE is projected to trade between $0.7099 and $1.71, averaging $1.06 — a potential gain of +51% from today's $0.69. That is -4% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Skye Bioscience, Inc.'s 2035 outlook centres on $1.37, within a $0.8991 to $2.24 range. That is up +29% on the projected 2034 average. That marks a +95% change versus current levels. Momentum favours further upside here.
By 2040, SKYE could reach as high as $2.87, with a base case around $1.63 and support toward $0.9938 — roughly +133% from $0.69. Buyers look set to stay in control over this stretch.
Expect SKYE to range from $1.87 to $6.83 through 2050. The $3.53 average target implies a +403% move from current prices. That is up +116% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SKYE today (≈ 1,449.275362 SKYE) could be worth
$5,109.28
+$4,109.28 (+411%) by 2050 · US Dollar
Based on the average projected SKYE price of $3.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SKYEwould be worth at today's price.
$1,000 invested in SKYE on Jul 10, 2025 (≈ 253.807103 SKYE) would be worth
$175.13
-$824.87 (-82.5%) today · 0.18× · US Dollar
Based on a SKYE entry price of $3.94 vs. today's $0.69.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.701 | $984.31 | -1.6% |
| 1 month ago | $0.78 | $884.62 | -11.5% |
| 3 months ago | $0.72 | $958.33 | -4.2% |
| 6 months ago | $0.941 | $733.26 | -26.7% |
| 1 year ago | $3.94 | $175.13 | -82.5% |
| All time (5.0y) ago | $41.25 | $16.73 | -98.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SKYE forecast.
Our base-case forecast reaches $1.40 around 2040.
Implied market cap at $1.40: $49.2M
The multi-year forecast shows a bullish trajectory beginning in the late 2020s, with the average price rising from $0.8606 in 2029 to $1.01 in 2030 (ROI 51.1%) and continuing to improve toward $1.23 in 2035 and $3.16 by 2050 (ROI 370.6%). The 2040 forecast envisions an average of $1.39 with a max near $2.61 and a 106.6% ROI, while 2030’s $1.01 average and 2050’s $6.62 max illustrate a meaningful long-run upside under bullish conditions.
These forecasts carry the implied sentiment trend of Neutral in 2026–2028 followed by Bullish from 2029 onward. As with any forecast, these are estimates, not guarantees, and actual results may differ due to market dynamics and other risks.
Tap a question to reveal the answer.
2030 forecast: avg $1.01, max $1.58, min $0.7035. ROI 51.1%. Sentiment: BULLISH.
Forecast shows Neutral in 2026–2028, then Bullish from 2029 onward, with 2050 avg $3.16 and max $6.62 and ROI 370.6%. These are estimates, not guarantees.
Yes. The 2035 max is $2.15 and the 2040 max is $2.61, with the 2050 max at $6.62.
The current price is $0.6705.
Near-term sentiment is BEARISH. RSI(14) is 40; SMA50 is $0.8011; SMA200 is $1.23. Support sits at $0.671 and resistance at $0.85, with a 30-day range of $0.5248–$0.8566.
Skye Bioscience, Inc. Community Discussion
0Share your Skye Bioscience, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.